GLP-1(87805-34-3)
- Name: GLP-1
- Synonyms:164: PN:WO0069900 SEQID: 343 unclaimed protein; 167: PN: WO2004005342 PAGE: 46 claimedprotein; 1: PN: WO0066142 SEQID: 1 unclaimed protein; 1: PN: WO0069911 SEQID: 1claimed protein; 1: PN: WO2009033711 PAGE: 1 claimed protein; 20: PN:WO2007028394 SEQID: 1 claimed protein; 276: PN: US20090175821 SEQID: 343claimed protein; 29: PN: WO2009099763 SEQID: 667 claimed protein; 2: PN:DE102004043153 PAGE: 13/17 claimed protein; 7: PN: WO2004005342 PAGE: 46claimed protein; 9: PN: US6284725 SEQID: 1 unclaimed protein; 9: PN: WO0066138PAGE: 11 unclaimed protein; Glucagon-like peptide I (ox); Glucagon-like peptideI (rat); Glycine, L-histidyl-L-a-aspartyl-L-a-glutamyl-L-phenylalanyl-L-a-glutamyl-L-arginyl-L-histidyl-L-alanyl-L-a-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-a-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-a-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-lysylglycyl-L-arginyl-;Human glucagon-like peptide 1; Rat GLP-I(1-37)
- Molecular Formula:C186H275 N51 O59
- Molecular Weight:4169.53
- CAS Registry Number:87805-34-3
- EINECS:201-258-5
- Melting Point:
- Water Solubility:Dissolved at 1 mg/ ml in 20% Acetonitrile and 80% water

Other Product
- 100311-40-8/2-(dimethylamino)ethyl 4-{[(E)-(dimethylamino)methylidene]amino}benzoate
- 53458-33-6/3-(5-chloro-5-deoxypentofuranosyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine
- 6291-92-5/(2,4,4-trimethylpentan-2-yl)cyanamide
- 51115-73-2/N,2,2-triethyl-3-methylbutyramide
- 55217-92-0/N-(4,5-Dihydro-4-methyl-2-sulfamoyl-1,3,4-thiadiazol-5-ylidene)-2,4,6-trimethoxybenzamide
- 106306-72-3/L-Arginine, N2-[1-(1-L-lysyl-L-prolyl)-L-prolyl]-
- 37195-33-8/Iron alloy,base,Fe 96-98,Cr 0.6-0.9,Ni 0.6-0.9,Mo 0.4-0.6,Mn 0.3-0.6,Si 0.2-0.4,C 0.2,V 0.1 (18KhNMFA)
- 73097-12-8/diethyl 9-methyl-7-oxo-7H-furo[3,2-g]chromene-2,6-dicarboxylate
- 113281-91-7/2,6-difluoro-N-{[4-(2-phenylethoxy)phenyl]carbamoyl}benzamide
- 124500-03-4/5-(4-chlorophenyl)-5-hydroxy-2-oxotetrahydrofuran-3-carbonitrile
- 565-98-0/3-alpha,20-beta-dihydroxy-5-beta-pregnan-11-one
- 19259-10-0/2,3,5-Triiodothiophene
- 5335-22-8/1-(2-chlorophenoxy)propan-2-ol
- 157773-35-8/2,7,8-Trioxabicyclo[3.2.1]octane-1-ethanethioicacid, 3-[(1a,3b,5a,6a,7a,20S)-6,7-epoxy-3-[(6-O-b-D-glucopyranosyl-b-D-glucopyranosyl)oxy]-1,5-dihydroxypregnan-20-yl]-a-hydroxy-5,6,6-trimethyl-,S-methyl ester (9CI)
- 5699-73-0/(2E)-N-cyclopropyl-3-(4-fluorophenyl)prop-2-enamide
- 30964-27-3/diethyl N-[(6-aminopyridin-3-yl)carbonyl]glutamate
- 125753-03-9/complement 3a(Tyr-70-77)
- 58969-44-1/5H-Pyrano[2,3-b]quinolin-5-one,2,3,4,10- tetrahydro-2,2-dimethyl-10-(3-methyl-2- butenyl)-
- 132122-83-9/dipropan-2-yl {[2-acetyl-2-(4-nitrophenyl)hydrazinyl]carbonyl}phosphonate
- 87805-34-3/GLP-1
- 6126-12-1/3,5-dimethyl-1-[(4-methylphenyl)sulfonyl]-1H-pyrazole
- 3695-97-4/2,5-dimethylhexa-1,5-diene-1,1,6,6-tetracarbonitrile
- 171485-67-9/b-D-Glucopyranosiduronic acid, (3b,16b)-16,28-epoxyolean-12-en-3-yl (9CI)
- 14415-46-4/[(4-{(E)-[(2-oxo-2H-chromen-6-yl)imino]methyl}phenyl)imino]diethane-2,1-diyl dimethanesulfonate
- 24465-30-3/1-Naphthalenepropanol, a-ethyldecahydro-5-(hydroxymethyl)-a,2,5,8a-tetramethyl-, (aR,1S,2S,4aR,5S,8aR)-
- 34540-26-6/Vobasan,4-demethyl-,(16R)-
- 52400-65-4/4-methyl-1-[2-(2-methyl-1,3-benzodioxol-2-yl)ethyl]piperazin-1-ium chloride
- 143004-42-6/Usneoidol E (9CI)
- 2826-75-7/N-[(7S)-1,2,3-trimethoxy-10-(methylsulfonyl)-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
- 137731-26-1/5-(propylsulfanyl)-4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepine